Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IMMX is expected to report earnings to fall 27.27% to -15 cents per share on December 03
Q3'25
Est.
$-0.16
Q2'25
Missed
by $0.01
Q1'25
Beat
by $0.08
Q4'24
Est.
$-0.25
Q3'24
Missed
by $0.08
The last earnings report on September 03 showed earnings per share of -21 cents, missing the estimate of -20 cents. With 54.27K shares outstanding, the current market capitalization sits at 64.01M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMMX showed earnings on September 03, 2025. You can read more about the earnings report here.